[go: up one dir, main page]

AU2002300605A1 - Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods - Google Patents

Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods

Info

Publication number
AU2002300605A1
AU2002300605A1 AU2002300605A AU2002300605A AU2002300605A1 AU 2002300605 A1 AU2002300605 A1 AU 2002300605A1 AU 2002300605 A AU2002300605 A AU 2002300605A AU 2002300605 A AU2002300605 A AU 2002300605A AU 2002300605 A1 AU2002300605 A1 AU 2002300605A1
Authority
AU
Australia
Prior art keywords
conjugates
antibody
protein
compositions
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002300605A
Other versions
AU2002300605B8 (en
AU2002300605B2 (en
Inventor
David N Brems
Donna L French
Margaret A Speed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU71327/98A external-priority patent/AU7132798A/en
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to AU2002300605A priority Critical patent/AU2002300605B8/en
Priority claimed from AU2002300605A external-priority patent/AU2002300605B8/en
Publication of AU2002300605A1 publication Critical patent/AU2002300605A1/en
Application granted granted Critical
Publication of AU2002300605B2 publication Critical patent/AU2002300605B2/en
Publication of AU2002300605B8 publication Critical patent/AU2002300605B8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002300605A 1997-04-17 2002-08-16 Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods Ceased AU2002300605B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002300605A AU2002300605B8 (en) 1997-04-17 2002-08-16 Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08843971 1997-04-17
US09059467 1998-04-14
AU71327/98A AU7132798A (en) 1997-04-17 1998-04-16 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
AU2002300605A AU2002300605B8 (en) 1997-04-17 2002-08-16 Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU71327/98A Division AU7132798A (en) 1997-04-17 1998-04-16 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods

Publications (3)

Publication Number Publication Date
AU2002300605A1 true AU2002300605A1 (en) 2003-02-13
AU2002300605B2 AU2002300605B2 (en) 2005-05-12
AU2002300605B8 AU2002300605B8 (en) 2006-02-09

Family

ID=39273443

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002300605A Ceased AU2002300605B8 (en) 1997-04-17 2002-08-16 Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods

Country Status (1)

Country Link
AU (1) AU2002300605B8 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9511935D0 (en) * 1995-06-13 1995-08-09 Smithkline Beecham Plc Novel compound
JP4037905B2 (en) * 1995-12-27 2008-01-23 ジェネンテック・インコーポレーテッド OB protein derivative with long half-life

Similar Documents

Publication Publication Date Title
HUP0002831A3 (en) Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
AU2228901A (en) Stable antibody compositions and injection preparations
AU1682699A (en) Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
AU1332099A (en) Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
AU5963900A (en) Muteins of bilin-binding protein
AU6058500A (en) Fusion protein and uses thereof
WO1999000010A3 (en) TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS
AU6030398A (en) Human proteins
AU7237496A (en) Methods and compositions comprising single chain recombinant antibodies
AU2002220843A1 (en) Humanised antibodies and uses thereof
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU3159499A (en) Antigen preparation and use
AU6585498A (en) Novel uncoupling protein and methods of use
ZA983239B (en) Stable active human ob protein compositions and methods
AU9017598A (en) Human frezzled-like protein
AU4974299A (en) Methods and constructs for protein expression
AU2002300605A1 (en) Compositions Comprising Conjugates of Stable, Active, Human OB Protein with Antibody FC Chain and Methods
AU1871999A (en) Inclusion complexes comprised of modified carbohydrates and agrochemical active ingredients
AU8750098A (en) General purpose combined harvester and thresher
FI971872A0 (en) Protein composition and its preparation and use, and preparations containing it and their preparation
AU3066197A (en) Human protein disulfide isomerase
AU3983899A (en) Human promonocyte associated protein: prmnc
AU7478098A (en) Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU2002243588A1 (en) Isolated bovine igg protein and its use as an antimicrobial agent
AU6227800A (en) Recombinant antibody directed against human sperm antigen